Contact Us
Drug Search Results
More Filters [+]

Gadobenic acid

Alternative Names: gadobenic acid, multihance, gadobenate dimeglumine
Latest Update: 2024-12-12
Latest Update Note: Clinical Trial Update

Product Description

Gadobenic acid (in the form of gadobenate dimeglumine) is an MRI contrast agent used primarily for MR imaging of the liver. It can also be used for visualizing the CNS and heart. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Gadobenic-acid)

Mechanisms of Action: Contrast Agent

Novel Mechanism: No

Modality: Diagnostic Agent

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Austria | Belgium | Bosnia | Brazil | Canada | Colombia | Croatia | Czech | Denmark | Egypt | Finland | France | Germany | Greece | Hong Kong | Hungary | India | Indonesia | Ireland | Israel | Italy | Korea | Luxembourg | Malaysia | Netherlands | New Zealand | Norway | Pakistan | Philippines | Poland | Portugal | Romania | Serbia | Singapore | Slovenia | South Africa | Spain | Sweden | Switzerland | Taiwan | Thailand | Turkey | United Kingdom | United States | Uruguay | Vietnam

Approved Indications: Kidney Diseases

Known Adverse Events: Headache

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Gadobenic acid

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

09/15/2023

News Article

 Despite the challenges posed by Covid-19, the global MRI Contrast Agents market Size is projected to grow at a CAGR of 5.8% during the 2023 to 2030 period

09/13/2023

News Article

 (2023-2031) Gadolinium Contrast Media Market Competition

07/19/2023

News Article

 Data Reinforcing Efficacy and Safety of Gadopiclenol in Contrast-Enhanced MRI of Certain Body Regions Published in Radiology

02/14/2023

News Article

 Preeminent Hospitals and Medical Practices Nationwide Lead in Patient Care with First Use of Bracco's VUEWAY™ (gadopiclenol) solution for injection for MRI

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions